Why is Godavari Drugs Ltd ?
1
Weak Long Term Fundamental Strength with a -0.27% CAGR growth in Net Sales over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.27 times
2
The company has declared Negative results for the last 4 consecutive quarters
- PAT(9M) At Rs 2.93 cr has Grown at -45.83%
- OPERATING CF(Y) Lowest at Rs 11.20 Cr
- NET SALES(9M) At Rs 75.96 cr has Grown at -21.64%
3
Below par performance in long term as well as near term
- Along with generating -40.86% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Godavari Drugs for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Godavari Drugs
-40.86%
-0.92
44.25%
Sensex
4.83%
0.41
11.83%
Quality key factors
Factor
Value
Sales Growth (5y)
-0.27%
EBIT Growth (5y)
3.90%
EBIT to Interest (avg)
2.39
Debt to EBITDA (avg)
3.62
Net Debt to Equity (avg)
1.37
Sales to Capital Employed (avg)
2.09
Tax Ratio
22.59%
Dividend Payout Ratio
0
Pledged Shares
0.22%
Institutional Holding
0.50%
ROCE (avg)
13.39%
ROE (avg)
13.97%
Valuation Key Factors 
Factor
Value
P/E Ratio
15
Industry P/E
34
Price to Book Value
1.27
EV to EBIT
14.20
EV to EBITDA
10.82
EV to Capital Employed
1.11
EV to Sales
1.08
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
9.13%
ROE (Latest)
8.54%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
Technical Movement
0What is working for the Company
NO KEY POSITIVE TRIGGERS
-10What is not working for the Company
PAT(9M)
At Rs 2.93 cr has Grown at -45.83%
OPERATING CF(Y)
Lowest at Rs 11.20 Cr
NET SALES(9M)
At Rs 75.96 cr has Grown at -21.64%
PBDIT(Q)
Lowest at Rs 1.99 cr.
OPERATING PROFIT TO NET SALES (Q)
Lowest at 7.47%
PBT LESS OI(Q)
Lowest at Rs 0.48 cr.
Loading Valuation Snapshot...
Here's what is not working for Godavari Drugs
Profit After Tax (PAT) - Nine Monthly
At Rs 2.93 cr has Grown at -45.83%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Net Sales - Nine Monthly
At Rs 75.96 cr has Grown at -21.64%
Year on Year (YoY)MOJO Watch
Near term sales trend is negative
Net Sales (Rs Cr)
Operating Cash Flow - Annually
Lowest at Rs 11.20 Cr
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Lowest at Rs 1.99 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Lowest at 7.47%
in the last five quartersMOJO Watch
Company's efficiency has deteriorated
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs 0.48 cr.
in the last five quartersMOJO Watch
Near term PBT trend is negative
PBT less Other Income (Rs Cr)






